Status:
COMPLETED
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
45+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the potential of RO4607381 to reduce cardiovascular morbidity and mortality in stable coronary heart disease patients with recent Acute Coronary Syndrome (ACS) and evaluate th...
Eligibility Criteria
Inclusion
- adult patients, \>=45 years of age;
- recently hospitalized for ACS;
- clinically stable;
- receiving evidence-based medical and dietary management of dyslipidemia.
Exclusion
- uncontrolled diabetes;
- clinically unstable;
- severe anemia;
- uncontrolled hypertension;
- concomitant treatment with any other drug raising HDL-C (eg niacin, fibrates).
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
15871 Patients enrolled
Trial Details
Trial ID
NCT00658515
Start Date
April 1 2008
End Date
September 1 2012
Last Update
January 3 2020
Active Locations (1089)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35213
2
Birmingham, Alabama, United States, 35215
3
Birmingham, Alabama, United States, 35235
4
Birmingham, Alabama, United States, 35294